80 related articles for article (PubMed ID: 7643450)
41. Preferentially Expressed Antigen of Melanoma (PRAME) and Wilms' Tumor 1 (WT 1) Genes Expression in Childhood Acute Lymphoblastic Leukemia, Prognostic Role and Correlation with Survival.
Khateeb EE; Morgan D
Open Access Maced J Med Sci; 2015 Mar; 3(1):57-62. PubMed ID: 27275197
[TBL] [Abstract][Full Text] [Related]
42. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 chromosomal translocation in hematologic malignancies.
Huang M; Li C; Liang H; Zhou J; Deng J; Liu W
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):661-3. PubMed ID: 17357482
[TBL] [Abstract][Full Text] [Related]
43. [WT1 gene expression difference in leukemia and non-leukemia and its clinical significance].
Liu HS; Zhu MS; Zhang HL; Wei SY; Wang XN; Xi XP; Yu FF; Xi JY; Wang MC; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1217-21. PubMed ID: 25338560
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory effect of curcumin on WT1 gene expression in patient leukemic cells.
Anuchapreeda S; Limtrakul P; Thanarattanakorn P; Sittipreechacharn S; Chanarat P
Arch Pharm Res; 2006 Jan; 29(1):80-7. PubMed ID: 16491848
[TBL] [Abstract][Full Text] [Related]
45. The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR.
Brieger J; Weidmann E; Maurer U; Hoelzer D; Mitrou PS; Bergmann L
Ann Oncol; 1995 Oct; 6(8):811-6. PubMed ID: 8589020
[TBL] [Abstract][Full Text] [Related]
46. Wilms tumor gene expression in acute myeloid leukemias.
Bergmann L; Maurer U; Weidmann E
Leuk Lymphoma; 1997 May; 25(5-6):435-43. PubMed ID: 9250813
[TBL] [Abstract][Full Text] [Related]
47. wt1 gene expression in childhood leukemias.
Niegemann E; Wehner S; Kornhuber B; Schwabe D; Ebener U
Acta Haematol; 1999; 102(2):72-6. PubMed ID: 10529509
[TBL] [Abstract][Full Text] [Related]
48. Recent advances in the treatment of acute leukemia.
Berman E
Curr Opin Hematol; 1997 Jul; 4(4):256-60. PubMed ID: 9260053
[TBL] [Abstract][Full Text] [Related]
49. [Analysis of LRP15 Gene Expression Pattern and Its Expression in Leukemia Cells].
Xu ZM; Yu L; Lu XC; Dou LP; Li M; Yang L; Zhao Y; Li HH; Lü M; Lü YL; Lou FD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):583-6. PubMed ID: 14706139
[TBL] [Abstract][Full Text] [Related]
50. Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells.
Zebisch A; Linkesch W; Sill H
Leukemia; 2005 Jan; 19(1):136-7. PubMed ID: 15510197
[No Abstract] [Full Text] [Related]
51. Molecular biology of leukemia for the clinician.
Paietta E
Med Oncol; 1995 Sep; 12(3):157-66. PubMed ID: 8852398
[TBL] [Abstract][Full Text] [Related]
52. Wilms' tumor 1 gene expression levels in acute promyelocytic leukemia compared to other acute myeloid leukemia subtypes.
Candoni A; Fanin R
Leuk Lymphoma; 2016 Feb; 57(2):498-499. PubMed ID: 26077364
[No Abstract] [Full Text] [Related]
53. Evaluating the role of Ubiquitin D gene expression in types of leukemia.
Zhao L; Liu D; Zhong C; Tang S; Li X; Zhu M; Li C
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):125-128. PubMed ID: 36905264
[TBL] [Abstract][Full Text] [Related]
54. Wt 15000.
Smith FH
Science; 1994 Jul; 265(5170):418-9. PubMed ID: 17838045
[No Abstract] [Full Text] [Related]
55. Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells.
Coelho-Dos-Reis JG; Huang J; Tsao T; Pereira FV; Funakoshi R; Nakajima H; Sugiyama H; Tsuji M
Clin Immunol; 2016 Jul; 168():6-15. PubMed ID: 27132023
[TBL] [Abstract][Full Text] [Related]
56. Chaperone-rich cell lysates, immune activation and tumor vaccination.
Zeng Y; Graner MW; Katsanis E
Cancer Immunol Immunother; 2006 Mar; 55(3):329-38. PubMed ID: 15887013
[TBL] [Abstract][Full Text] [Related]
57. Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells.
Zeng Y; Graner MW; Thompson S; Marron M; Katsanis E
Blood; 2005 Mar; 105(5):2016-22. PubMed ID: 15374884
[TBL] [Abstract][Full Text] [Related]
58. [WT 1 and leukemia].
Inoue K; Sugiyama H
Rinsho Ketsueki; 1995 Jun; 36(6):552-8. PubMed ID: 7643450
[TBL] [Abstract][Full Text] [Related]
59. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.
Inoue K; Sugiyama H; Ogawa H; Nakagawa M; Yamagami T; Miwa H; Kita K; Hiraoka A; Masaoka T; Nasu K
Blood; 1994 Nov; 84(9):3071-9. PubMed ID: 7949179
[TBL] [Abstract][Full Text] [Related]
60. Expression patterns of WT-1 and Bcr-Abl measured by TaqMan quantitative real-time RT-PCR during follow-up of leukemia patients with the Ph chromosome.
Chen ZX; Kaeda J; Saunders S; Goldman JM
Chin Med J (Engl); 2004 Jul; 117(7):968-71. PubMed ID: 15265366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
